Manufacturer
Emergent BioSolutions Canada
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 2
- Molecules
- 2
- Therapy areas
- 0
Emergent BioSolutions Canada is a pharmaceutical manufacturer based in United States. MedsAcross lists 2 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Emergent BioSolutions Canada Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Emergent BioSolutions Canada products through licensed channels, with the documents your regulator needs.
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Anthrasil 60 IU/35 mL injectionIntravenous Cold chain | Anthrax immune globulin human | US FDA | Available on request |
| Cnj-016 1 IU/mL injectionIntravenous Cold chain | Human vaccinia virus immune globulin | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Emergent BioSolutions Canada
Send a request for any of these products. We confirm the licensed source, documents and lead time.